Table 1

Patient demographics and oncologic characteristics (N=372)

Characteristic*All patients
(N=372)
Patients with obesity on problem list
(N=202)
Patients without obesity on problem list
(N=170)
P value
Age at index visit (years)64 (58, 71)63 (55, 69)66 (60, 72)0.002
BMI at index visit (kg/m²)38.7 (34.6, 45.3)41.5 (36.9, 48.7)35.7 (32.7, 40.1)<0.001
Weight at index visit (kg)103.6 (92.4, 123.6)113.5 (96.1, 134.6)96.4 (86.7, 106.2)<0.001
Race†0.93
 White321 (88%)175 (88%)146 (88%)
 Black37 (10%)21 (11%)16 (10%)
 Other‡8 (2%)4 (2%)4 (2%)
Ethnicity§0.65
 Non-Hispanic346 (98%)188 (97%)158 (98%)
 Hispanic8 (2%)5 (3%)3 (2%)
ASA status¶0.02
 I1 (<1%)0 (0%)1 (<1%)
 II53 (17%)24 (13%)29 (21%)
 III241 (75%)138 (75%)103 (75%)
 IV26 (8%)21 (11%)5 (4%)
Tobacco use0.57
 Never281 (76%)153 (76%)128 (75%)
 Current17 (5%)11 (5%)6 (4%)
 Former73 (20%)37 (18%)36 (21%)
Insurance0.12
 Private151 (41%)94 (47%)57 (34%)
 Medicare211 (57%)102 (51%)109 (64%)
 Medicaid3 (1%)2 (1%)1 (1%)
 Uninsured4 (1%)2 (1%)2 (1%)
 Other3 (1%)2 (1%)1 (1%)
Chronic conditions (n)0.17
 124 (6%)11 (5%)13 (7%)
 246 (12%)20 (10%)26 (15%)
 3+302 (81%)171 (85%)131 (77%)
Charlson Comorbidity Index4 (3, 6)4 (3, 7)3 (4, 6)0.58
Marital status**0.42
 Single65 (18%)37 (19%)28 (17%)
 Married213 (58%)109 (55%)104 (62%)
 Widowed35 (10%)18 (9%)17 (10%)
 Divorced52 (14%)34 (17%)18 (11%)
 Other††3 (1%)2 (1%)1 (1%)
Distance from VUMC (miles)35.7 (20.1, 81.3)34.7 (18.8, 69.0)36.9 (21.4, 85.1)0.29
Stage of disease‡‡0.33
 I292 (81%)162 (84%)130 (78%)
 II19 (5%)11 (6%)8 (5%)
 III31 (9%)12 (6%)19 (11%)
 IV18 (5%)9 (5%)9 (5%)
Phase of care0.12
 Primary disease33 (9%)20 (10%)13 (8%)
 Surveillance/survivorship312 (84%)173 (86%)139 (82%)
 Recurrence16 (4%)6 (3%)10 (6%)
 Recurrence, last year of life11 (3%)3 (1%)8 (5%)
Prior oncologic treatments
 New diagnosis (no treatment yet)7 (2%)5 (2%)2 (1%)0.36
 Chemotherapy99 (27%)45 (22%)54 (32%)0.04
 Hormonal therapy23 (6%)15 (7%)8 (5%)0.28
 Surgery348 (94%)184 (91%)164 (96%)0.04
 Radiation101 (27%)48 (24%)53 (31%)0.11
 Other3 (1%)0 (0%)3 (2%)0.06
 Unknown1 (<1%)0 (0%)1 (1%)0.23
Prior lines of chemotherapy (n)0.48
 176 (78%)36 (80%)40 (74%)
 215 (15%)7 (16%)8 (15%)
 3+8 (8%)2 (4%)6 (11%)
Provider at time of index visit0.03
 A23 (6%)9 (4%)14 (8%)
 B84 (23%)41 (20%)43 (25%)
 C72 (19%)32 (16%)40 (24%)
 D49 (13%)27 (13%)22 (13%)
 E70 (19%)46 (23%)24 (14%)
 F1 (<1%)0 (0%)1 (1%)
 G73 (20%)47 (23%)26 (15%)
  • *Percentages exclude missing data. Chi-squared and Fisher’s exact tests were used for categorical variables, and Mann–Whitney test to compare medians between cohorts for continuous variables. Percentages may not total 100% due to rounding.

  • †Unknown or missing data for 6 patients.

  • ‡Includes American Indian or Alaska Native (1), Chinese (1), Filipino (1), Other Asian (1), and Other (4).

  • §Unknown or missing data for 18 patients.

  • ¶Unknown or missing data for 51 patients.

  • **Unknown or missing data for 4 patients.

  • ††Other category includes 1 patient with significant other, 1 patient legally separated, 1 other. Unknown or missing data for 4 patients.

  • ‡‡Unknown or missing data for 12 patients.

  • ASA, American Society of Anesthesiology; BMI, body mass index; VUMC, Vanderbilt University Medical Center.